8-K current report · filed Aug 13, 2026

Rocket Lab Corp (RKLB) 8-K Current Report: August 13, 2026

Item 7.01Item 8.01Item EX-99.1Item EX-99.2RKLB overview

Short answer

Rocket Lab Corp (RKLB) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). August 13, 2026 press release announced an Equity Distribution Agreement, signaling potential equity issuance and shareholder dilution risk.

Rocket Lab Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • August 13, 2026 press release announced an Equity Distribution Agreement, signaling potential equity issuance and shareholder dilution risk
  • Separate release reported progress toward Rocket Lab’s proposed acquisition of Iridium Communications, a potentially transformative strategic transaction
  • Investors should review Exhibits 99.1 and 99.2 for financing terms, transaction milestones, and expected shareholder impact

Item 8.01 · Other Events

  • ATM equity program authorizes up to $1.944B in common-stock sales, creating substantial funding capacity but potential shareholder dilution
  • Sales-agent commissions up to 2.00%, reducing net proceeds and increasing capital-raising costs
  • Forward contracts defer proceeds until settlement, with cash, share-delivery, and counterparty hedge risks
  • Collared forwards establish floor and cap pricing, limiting downside proceeds and upside participation
  • Stock-borrowing constraints could reduce forward transaction size, potentially to zero shares

Item EX-99.1 · Exhibit EX-99.1

  • Replacement ATM program authorizes up to $1,944,369,826, carrying forward the prior agreement’s unsold capacity without increasing total shares offered
  • Proceeds intended for cash payments tied to the proposed Iridium acquisition and reductions to the senior secured debt bridge facility
  • Equity issuance is not contingent on completing Iridium, preserving funding flexibility but creating potential shareholder dilution
  • Excess proceeds could fund future acquisitions, growth initiatives, and general corporate or working capital needs

Item EX-99.2 · Exhibit EX-99.2

  • HSR antitrust waiting period expired August 12, advancing the proposed Iridium acquisition without early U.S. antitrust intervention
  • Form S-4 filed August 13 to register Rocket Lab shares for Iridium shareholders, moving the transaction toward shareholder approval
  • FCC applications filed August 10 to transfer Iridium licenses and authorizations, with regulatory approval still outstanding
  • $3.6B, 364-day bridge facility targeted for replacement with permanent debt and equity financing
  • Iridium’s $1.775B term loan may remain outstanding at lower rates, subject to lender consent; new ATM equity program supports bridge refinancing

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Rocket Lab Corp 8-K filings

Get the next RKLB 8-K as it lands

Follow RKLB for push alerts, or ask the research agent what this filing means.